Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.14 | N/A |
| PEG Ratio (TTM) | -1.89 | N/A |
| P/S Ratio (TTM) | 1.89 | N/A |
| P/B Ratio (TTM) | 0.96 | N/A |
| P/FCF Ratio (TTM) | 16.46 | N/A |
| Price to 5YR AVG Earnings Ratio | 10.04 | N/A |
| Price to 5YR AVG FCF Ratio | 7.79 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.82% | N/A |
| ROE (TTM) | 8.87% | N/A |
| Net Profit Margin (TTM) | 16.80% | N/A |
| ROIC 5YR AVG | 12.30% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -5.39% | 40.70% | 20.90% |
| Revenue | 3.51% | 4.75% | 4.26% |
| Net Income | -5.28% | 39.74% | 20.18% |
| Cash Flow | 49.77% | 11.60% | 13.03% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 6.59 | N/A |
| Quick Ratio (TTM) | 6.59 | N/A |
| D/E Ratio (TTM) | 0.58 | N/A |
| Interest Coverage (TTM) | 0.96 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.51 | N/A |
| LTL to 5YR AVG FCF | 2.25 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.05% | N/A |